azuletil has been researched along with Chronic Disease in 2 studies
*Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kishimoto, S; Kosakai, K; Matsumoto, M; Mochizuki, S; Tomiyama, A; Wakabayashi, S | 1 |
Kosakai, K; Matsumoto, M; Mochizuki, S; Okabe, S; Sekiguchi, H; Takeuchi, K; Takeuchi, M; Tomiyama, A; Wakabayashi, S | 1 |
2 other study(ies) available for azuletil and Chronic Disease
Article | Year |
---|---|
Therapeutic effect of egualen sodium (KT1-32), a new antiulcer agent, on chronic gastritis induced by sodium taurocholate in rats.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Anti-Ulcer Agents; Azulenes; Cell Count; Cell Division; Chalcone; Chalcones; Chronic Disease; Dose-Response Relationship, Drug; Gastric Mucosa; Gastritis; Male; Mucus; Parietal Cells, Gastric; Rats; Rats, Wistar; Sesquiterpenes; Sesquiterpenes, Guaiane; Taurocholic Acid; Treatment Outcome | 1996 |
[Healing promoting effect of azuletil sodium (KT1-32) on experimental chronic gastric ulcers and acceleration of healing in SPF environment].
Topics: Animals; Anti-Ulcer Agents; Azulenes; Chronic Disease; Male; Rats; Rats, Inbred Strains; Sesquiterpenes; Specific Pathogen-Free Organisms; Stomach Ulcer | 1991 |